PROTECTING FIRST RESPONDERS FROM EXPOSURE TO FENTANYL

Similar documents
MODUS OPERANDI FENTANYL. Control No.: P-693/

Penicillin G Procaine in Sesame Oil

1. IDENTIFICATION OF SUBSTANCE Name: ALUMINUM CHLORIDE SOLUTION 30% Manufacturer:

FENTANYL AND CARFENTANIL EXPOSURE IN PARAMEDIC SERVICES

SAFETY DATA SHEET. 2 Fleetwood Court Ronkonkoma, NY Skin Irritant 3. Causes mild skin irritation (H316)

1. IDENTIFICATION OF SUBSTANCE PODOPHYLLUM RESIN 25-50% IN BENZOIN Name: TINCTURE

Material Safety Data Sheet

Material Safety Data Sheet According to ISO Page 1 of 5 ; 1. IDENTIFICATION OF SUBSTANCE

1. IDENTIFICATION OF SUBSTANCE OXYMETAZOLINE & TETRACAINE TOPICAL Name: SOLUTION

MATERIAL SAFETY DATA SHEET

Evidence Unit Safety Protocols in Light of Fentanyl Concerns

SAFETY DATA SHEET 1. CHEMICAL PRODUCT AND COMPANY IDENTIFICATION 2. HAZARDS IDENTIFICATION

Material Safety Data Sheet According to ISO Page 1 of 6

Safety Data Sheet CITRA FORCE

MATERIAL SAFETY DATA SHEET SECTION 1 IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND OF THE COMPANY/UNDERTAKING

/pdf/ Tue Jul 02 07:46: EFB504S0 MATERIAL SAFETY DATA SHEET

Westco Chemicals, Inc Saticoy Street South - North Hollywood, CA TEL: FAX:

Alcohol Prep Pads (private label included) This product is intended for use as a skin antiseptic. It is for external use only.

SAFETY DATA SHEET. Emergency Telephone Number: (24/7/365) English Only

FOOTBALL WHEN LEAKS MUST BE STOPPED! Material Safety Data Sheet FlowStop FootBall TM. 1. Product and Company Identification

/pdf/ Tue Jul 02 07:53: HFB605T3 MATERIAL SAFETY DATA SHEET

Material Safety Data Sheet According to REACH regulation 1907/2006 Annex II

/pdf/ Wed Jan 08 07:57: PFB652S6 MATERIAL SAFETY DATA SHEET

SAFETY DATA SHEET BWT-27

Safety Data Sheet. Product Name: Product Number: Product Identity. 2. Hazardous Ingredients. Formaldehyde: CAS: Methanol: CAS:

Directions for the Creation and Use of GHS Labels

SAFETY DATA SHEET. Oxycodone Hydrochloride (CII) Capsule, 5mg, 100 count bottle NDC

MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET

Material Safety Data Sheet. Mitomycin for Injection

MATERIAL SAFETY DATA SHEET

Material Safety Data Sheet CISPLATIN INJECTION SECTION 2 COMPOSITION, INFORMATION ON INGREDIENTS

NITROGLYCERIN INJECTION 50 mg/ml Department of Pharmacy Duke University Medical Center Box 3089 Durham, NC

Safety Data Sheet AERO VOMIT CONTROL. SECTION 1: Identification. SECTION 2: Hazards Identification 1.00 ENG 2.00

MATERIAL SAFETY DATA SHEET

SAFETY DATA SHEET SECTION 1: PRODUCT IDENTIFICATION PRODUCT: Hand Sanitizer Product Label Name:

SAFETY DATA SHEET CWT-9

Safety Data Sheet European Format

MATERIAL SAFETY DATA SHEET

/pdf/ Wed Sep 03 07:54: PFB690S2 MATERIAL SAFETY DATA SHEET

Pulpdent Corporation Revision Date: January 1, 2014

Safety Data Sheet 1511BR

/pdf/ Tue Jul 02 07:51: ELW405P9 MATERIAL SAFETY DATA SHEET

SAFETY DATA SHEET. Product Name: HUMIPLUS ULTIMATE ZN CHELATE. Page 1 of 5. Classification of the Substance or Mixture.

MATERIAL SAFETY DATA SHEET

Safety Data Sheet. Isosorbide Mononitrate Extended Release Tablets 30 mg, 60 mg and 120 mg Oxycodone Hydrochloride Tablets 10mg

MATERIAL SAFETY DATA SHEET

Pulpdent Corporation Revision Date: May 7, 2014

MATERIAL SAFETY DATA SHEET GENERAL HYDROPONICS ph Up TM Dry Concentrate 3/12/09 SECTION 2. INGREDIENTS AND OCCUPATIONAL EXPOSURE LIMITS

MATERIAL SAFETY DATA SHEET

Synthetic Opioid/Fentanyl Processing

Material Safety Data Sheet. טרופר - Trooper. Name CAS no. Quantity (%) Cyromazine (N-cyclopropyl-1,3,5- triazine-2,4,6-triamine)

SAFETY DATA SHEET Foaming Carwash

AMBULANCE DECONTAMINATION GUIDELINES SUSPECTED INFLUENZA PATIENT

/pdf/ Tue Jul 02 07:47: EFH400S9 MATERIAL SAFETY DATA SHEET

CAS No.: Chemical Name: (R)-[(2,6-dimethylphenyl)-methoxyacetylamino]-propionic acid methyl ester Chemical Class: Phenylamide Fungicide

RNZ INTERNATIONAL FZE MSDS. SECTION 1. Product And Company Identification. Company Name: RNZ INTERNATIONAL FZE

/pdf/ Wed Jan 15 14:37: PFH502S8 MATERIAL SAFETY DATA SHEET

/pdf/ Mon Jan 20 13:24: PFR400S9 MATERIAL SAFETY DATA SHEET

Use only for the purpose on the product label.

/pdf/ Tue Feb 25 14:03: PFY500S8 MATERIAL SAFETY DATA SHEET

Naval Support Activity Monterey / Naval Postgraduate School

MATERIAL SAFETY DATA SHEET

DuPont StoneTech Professional POLISHING POWDER 900

SAFETY DATA SHEET BWT-12 P

0800 POISON HSNO Classifications: 6.1C, 6.3A, 6.9A, 8.1A, 9.1A, 9.3C

MATERIAL SAFETY DATA SHEET

/pdf/ Fri Feb 21 13:01: PFW510S9 MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET

ITTEHAD CHEMICALS LIMITED Kala Shah Kaku

MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET

/pdf/ Tue Jul 02 07:51: ELW505S9 MATERIAL SAFETY DATA SHEET

Safety Data Sheet Cola Cap MA259

Safety Data Sheet. Industrial PRODUCT AND COMPANY IDENTIFICATION. HAZARDS IDENTIFICATION Classification of the Substance or Mixture

Pulpdent Corporation Revision Date: May 1, 2017

MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET

Facts About VX. What VX is

SAFETY DATA SHEET. House and Garden Amino Treatment

MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET MSDS L-258 REVISION 2

Zoledronic Acid Accord 4 mg/5 ml

Issued Date 03/12/2012 I. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND COMPANY PRODUCT: VIRKON-S Tablets EPA REG #

Pulpdent Corporation Revision Date: May 1, 2017

KEY PRODUCT FOR HL SAFETY DATA SHEET

Pulpdent Corporation Revision Date: May 1, 2017 Safety Data Sheet

Kovanaze TM Nasal Spray (6 mg Tetracaine Hydrochloride and 0.1 mg Oxymetazoline Hydrochloride per 0.2 ml spray)

M A T E R I A L S A F E T Y D A T A S H E E T

SAFETY DATA SHEET Confirms to OSHA Hazard Communication Standard (CFR ) HazCom 2012

MATERIAL SAFETY DATA SHEET

Safe Handling of 10% Neutral Buffered Formalin

House and Garden Soil A

MATERIAL SAFETY DATA SHEET

SECTION 1: IDENTIFICATION

SAFETY DATA SHEET Confirms to OSHA Hazard Communication Standard (CFR ) HazCom 2012

MATERIAL SAFETY DATA SHEET

Safety Data Sheet European Format

1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND OF THE COMPANY/UNDERTAKING

Transcription:

PROTECTING FIRST RESPONDERS FROM EXPOSURE TO FENTANYL This document establishes interim guidance for first responders who may be exposed to fentanyl and other related substances while on the job. 1 There is a significant threat to first responders who may encounter fentanyl and other related substances through routine job activities. The National Institute for Occupational Safety and Health (NIOSH) has identified the following job categories as positions where responders might come into contact with fentanyl or its analogues. Pre-Hospital Patient Care: Emergency medical services providers, including first responders, fire department and private companies who attend to individuals with suspected fentanyl overdose. Responders may encounter drugs or drug paraphernalia on or near the patient. Law Enforcement: Law enforcement officers who perform day-to-day law enforcement duties. Law enforcement officers may come into contact with fentanyl during the course of their daily activities such as traffic stops, apprehending and searching subjects, and responding to fentanyl overdose calls. Although not recognized by NIOSH, we know from experience that Corrections personnel may encounter contraband fentanyl. Investigation and Evidence Handling: Law enforcement personnel who conduct investigations related to fentanyl. Activities may include executing search warrants and collecting, transporting, and storing evidence. Evidence collection activities in the field have the potential to aerosolize powders. Also, law enforcement personnel who handle evidence in the chain of custody have the potential to encounter fentanyl unless controls are in place to prevent exposures. Special Operations and Decontamination: Workers who conduct special operations where exposure to large amounts of fentanyl are expected. Examples include hazardous material incident response teams responding to a release or spill, and law enforcement officers executing search warrants on opioid processing or distribution sites, or participating in other tactical operations. These activities may aerosolize powders. Illicit Use Fentanyl is 50 times more potent than heroin and is often mixed with heroin to increase potency. It has also been sold as a substitute for as heroin so dealers and buyers may not know exactly what they are selling or using. Fentanyl is also sold and used as a standalone drug. 1 Interim guidance for PPE are based on the reported toxicity and chemical structure of fentanyl, and the basic principles of industrial hygiene. Standard safe work practices must to be applied to all operations where fentanyl or its analogs are known to be present.

Routes of Exposure Fentanyl can be inhaled in powder form, orally ingested through pills, mixed with liquid and injected and rapidly absorbed both orally and through the skin using blotter paper and patches. Due to the high potency of fentanyl and fentanyl-related substances, exposure to small quantities can cause serious negative health effects, respiratory depression and even death. Worker Training Responders who perform jobs where fentanyl or its analogues are reasonably anticipated to be present should receive special training in conducting an on-scene risk assessment related to fentanyl and its analogues and demonstrate an understanding of the following: How to recognize the form and determine the quantity of the suspected fentanyl and other drugs. When to use Personal Protective Equipment (PPE); what PPE is necessary; how to properly put on, use, take off, properly dispose of, and maintain PPE; and the limitations of PPE. What the potential exposure routes are for fentanyl and its analogues. How to recognize the signs and symptoms of opioid exposure. When and how to seek medical help. Scene Risk Assessment First responders should determine the risk level based on a scene risk assessment of the specific mission responsibilities and work environment that include the presence of hazards and the likelihood of exposure. Do not conduct field tests when fentanyl substances are suspected. Upon arrival, personnel should carefully examine the environment and situation before proceeding. This risk assessment should consider: The available information regarding the potential presence of synthetic opioids; The first responder s duration of exposure to materials; Person is unconscious and cause is unknown; Form of drugs exposed e.g. pill vs powder; and Packaging of drugs present on the person e.g. pill containers, folded pieces of paper. Personal Protective Equipment The following table provides PPE recommendations for protection against fentanyl and its analogues. Identifying the PPE appropriate for the risk is done by first selecting the correct job category, as defined above, and then the level of exposure anticipated. Exposure levels are defined as follows: Minimal: Response to a situation where it is suspected that fentanyl may be present but no fentanyl products are visible o Example: An EMS response to a suspected fentanyl overdose or law enforcement operation where intelligence indicates fentanyl products are suspected but are not visible on scene 2

Moderate: Response to a situation where small amounts of fentanyl products are visible o Example: An EMS response to a suspected fentanyl overdose or law enforcement operation where fentanyl products are suspected and small amounts are visible on scene High: Response to a situation where liquid fentanyl or large amounts of fentanyl products are visible o Example: A fentanyl storage or distribution facility, fentanyl milling operation, or fentanyl production laboratory It is important to recognize that the exposure level initially selected can change and PPE should be adjusted accordingly. Additionally, higher levels of PPE may be necessary to protect responders from exposure to other chemicals that may also be present in addition to fentanyl. These recommendations cover examples of common exposures, but are not intended to prescribe PPE for every responder or exposure or discuss all PPE options. In all cases, employers must identify hazards to which their workers might be exposed and provide appropriate PPE to protect them. All PPE should be used in accordance with OSHA s PPE standard (29 CFR 1910.132). When required, respirator use should be in the context of a comprehensive respiratory protection program in accordance with the OSHA respiratory protection standard (29 CFR 1910.134) and other requirements. Responders who need to wear respirators must be medically cleared, trained, and fit-tested for respirator use. 3

Personal Protective Equipment Recommendations for Protection Against Fentanyl Disposable N100, R100 or P100 FFR 1 Pre-Hospital Patient Care Law Enforcement Routine Duties Investigations and Evidence Collection Special Operations and Decontamination Min Mod High Min Mod High Min Mod High Min Mod High Elastomeric APR 2 PAPR 3 SCBA 4 Safety Goggles/ Glasses 5 Nitrile Gloves 6 Nitrile Gloves, Double or Use of Thicker Gloves Wrist/Arm Protection 7 Particulate Hazard Protective Ensemble Chemical Hazard Protective Ensemble 1. FFR: Filtering facepiece respirator, N: not resistant to oil, P: oil-proof, R: resistant to oil 2. APR: Air-purifying respirator 3. PAPR: Powered air-purifying respirator 4. SCBA: Self-contained breathing apparatus 5. Face and eye protection is recommended when the respirator does not provide this type of protection 6. Powder-free nitrile gloves 7. Wrist/arm protection may include one or more of the following: on-duty uniform with sleeves, sleeve covers, gowns or coveralls. KEY Minimum protection recommended When an on-scene risk assessment is conducted and higher protection is warranted. If particulate + gas/vapor hazard is expected above the immediately dangerous to life or health (IDLH) values or concentration is unknown, SCBA is recommended. NOT RECOMMENDED, REFER SCEEN TO SPECIAL OPERATIONS RESPONSE WORKERS (SUCH AS HAZMAT TEAM) NOT RECOMMENDED, REFER SCEEN TO SPECIAL OPERATIONS RESPONSE WORKERS (SUCH AS HAZMAT TEAM) 4

Decontamination The purpose of decontamination is to make an individual and the environment safe by physically removing toxic substances quickly and effectively. Care should be taken during decontamination, because absorbed agents can be released from clothing and skin. Individual Decontamination: The following methods can be used to decontaminate an individual: Remove the victim from the contaminated area and into the decontamination area; Remove all contaminated clothing and place in a labeled durable 6-mil polyethylene bag; Thoroughly wash and rinse (using cold or warm water) the contaminated skin of the victim using a soap and water solution. Be careful not to break the victim s skin during the decontamination process and cover all open wounds; Cover the victim to prevent shock and loss of body heat; and Move the victim to an area where emergency medical treatment can be provided. Environmental Decontamination: The following methods can be used to decontaminate the environment: Avoid touching or walking through the spilled agent. However, if you must, personnel should wear the appropriate PPE (see the PPE section of this fact sheet for detailed information); Keep combustibles (wood, paper and oil) away from the spilled agent. Use water spray to reduce vapors or divert vapor cloud drift. Avoid allowing water runoff to contact the spilled agent; Do not direct water at the spill; Stop the spill only if it is possible to do so without risk to personnel; Prevent entry into waterways, sewers, basements, or confined areas; Isolate the area until aerosolized spray has dispersed; and Ventilate the area. First Aid General Information: Treatment consists of administration of the antidote and aggressive support of respiratory function. Contact Emergency Medical Services immediately if you suspect exposure to fentanyl or any opioid. Antidote: Naloxone has been recommended for treatment of opioid poisoning, including those caused by Fentanyl. 2 Naloxone should be used during pregnancy only if the possible benefit outweighs the possible risk to the unborn baby. Naloxone is commonly given intramuscularly or in a spray form through the nasal passage. After 2-3 minutes if there is no responsiveness (no breathing/no pulse/unresponsiveness), or the individual responds but then relapses into respiratory depression, administer another dose of naloxone. Eye: Wash eyes with a steady stream of tepid water for at least 15 minutes; and 2 Check your local laws to see if pharmacies in your state can give you take home Naloxone (without bringing in a prescription). 5

Ingestion: Ensure that the victim has an unobstructed airway; Do not induce vomiting; Administer naloxone under healthcare provider s direction; and Inhalation: Skin: Evaluate respiratory function and pulse; Ensure that the victim has an unobstructed airway; If shortness of breath occurs or breathing is difficult, administer oxygen; Assist ventilation as required using a barrier or bag-valve-mask device; If breathing has ceased, provide artificial respiration using a barrier or bag-valve-mask device; Monitor the victim for signs of whole-body effects; 3 If signs of whole-body poisoning appear, see the Ingestion section for treatment recommendations; and See the Decontamination section for victim decontamination procedures; Monitor the victim for signs of whole-body effects; If signs of whole-body poisoning appear, see the Ingestion section for treatment recommendations; and Source Material Much of the content of this document is taken from The Center for Disease Control and Prevention, National Institute for Occupational Safety and Health (NIOSH). 4 Although other Governmental and Non-Governmental organizations have made recommendations for worker protection from exposure to fentanyl and its analogs, the interim recommendations proposed by NIOSH offer the best level of protection. (October 18, 2017) 3 Whole-body effects include: contracted, pinpoint or dialed pupils, reduced level of consciousness, reduced respiratory function, reduced blood oxygen content, accumulation of acid in the blood, low blood pressure, slow heart rate, shock, slowing of muscular movement of the stomach intestinal obstruction due to lack of normal muscle function, accumulation of fluid in the lungs, lethargy, coma, and death. 4 See Fentanyl: Preventing Occupational Exposure to Emergency Responders (http://bit.ly/2sn3j0l) for further detail. 6